Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Change in Acquisitions & Divestments (2020 - 2025)

Ovid Therapeutics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 86.84% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $42.0 million, down 67.19%, while the annual FY2025 figure was $42.0 million, 67.19% down from the prior year.
  • Change in Acquisitions & Divestments reached $5.0 million in Q4 2025 per OVID's latest filing, down from $10.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $60.0 million in Q4 2022 to a low of $5.0 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 4 years is $27.1 million, with a median of $27.5 million recorded in 2022.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 280.0% in 2024, then tumbled 86.84% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $60.0 million in 2022, then plummeted by 83.33% to $10.0 million in 2023, then skyrocketed by 280.0% to $38.0 million in 2024, then crashed by 86.84% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for OVID's Change in Acquisitions & Divestments are $5.0 million (Q4 2025), $10.0 million (Q3 2025), and $17.0 million (Q2 2025).